Oncology Recruitment AI Leverage the VIPER platform to accelerate oncology trial recruitment by matching newly diagnosed cancer patients to appropriate trials, a compelling value proposition for sponsors and CROs seeking faster enrollment; align with Paradigm’s client base for a joint go-to-market.

Feasibility Advantage Position Real Time Feasibility as a strategic tool to optimize trial site selection and patient flow, reducing screening inefficiencies and shortening study start-up timelines; tailor outreach to sponsors and site networks looking to improve feasibility accuracy.

Pathology Platform Cross-sell the digital pathology platform to labs and cancer centers expanding AI-enabled pathology workflows; integrate pathology AI insights into trial readiness and patient eligibility assessments to broaden use cases.

Partnership Expansion Leverage a proven collaboration track record with academic centers and pharma partners to expand the partner ecosystem; target oncology centers, CROs, and biopharma firms for joint pilots combining patient matching, feasibility, and trial operations tools.

Strategic Positioning Capitalize on strategic acquisition by Paradigm and strong funding to position as a scalable cloud-based platform; propose enterprise contracts with flexible tiers and long-term collaborations that align with sponsor needs and trial networks.